China Shineway Pharmaceutical Group Limited (FRA:C1S)

Market Cap	777.28M
Revenue (ttm)	397.48M
Net Income (ttm)	98.45M
Shares Out	n/a
EPS (ttm)	0.13
PE Ratio	7.90
Forward PE	7.60
Dividend	0.06 (5.75%)
Ex-Dividend Date	Sep 9, 2025

Volume	n/a
Average Volume	45
Open	1.0100
Previous Close	1.0100
Day's Range	0.9950 - 1.0100
52-Week Range	0.7850 - 1.1100
Beta	n/a
RSI	65.21
Earnings Date	Mar 29, 2026

About FRA:C1S

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, ortho...

• Industry: Pharmaceutical Preparations
• Founded: 2002
• Employees: 3,220
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: C1S

Financial Performance

In 2024, FRA:C1S's revenue was 3.78 billion, a decrease of -16.35% compared to the previous year's 4.52 billion. Earnings were 840.05 million, a decrease of -13.35%.

Financial numbers in CNY